Lv0
0 积分 2024-11-04 加入
Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Population‐Based Cohort Study
4小时前
待确认
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019
2个月前
已完结
Plasma FSTL-1 as a non-invasive diagnostic biomarker for patients with advanced liver fibrosis
5个月前
已完结
Sa340 ASSESSMENT OF THE LIKELIHOOD OF HEPATIC DECOMPENSATION & PORTAL HYPERTENSION USING NONINVASIVE TECHNIQUES IN NAFLD-CIRRHOTIC PATIENTS
6个月前
已关闭
Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis
6个月前
已完结
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
6个月前
已完结
皖公网安备34019202002308
